Filed: February 27, 2021 00:00
Coverage
-
September 13, 2022
A split Patent Trial and Appeal Board panel has determined that Intel Corp. failed to show that six claims it challenged in a Health Discovery Corp. patent on using machine learning to identify genes underlying certain medical conditions are invalid.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Search PTAB cases and full-text documents.
- Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
- Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!
TRY LAW360 FREE FOR SEVEN DAYS